Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.432 USD | +2.86% | -6.09% | -38.37% |
May. 10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
514M | - | - | - | - | - | |
124B | ||||||
111B | ||||||
23.17B | - | |||||
22.94B | - | |||||
17.42B |